India has tweaked requirements around audio-visual recording of the informed consent process for clinical trials, relaxing the rules a little for HIV and leprosy drugs, but industry claims that the revised norms lack clarity on certain key aspects.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?